MinuteClinic offers free A1c tests
WOONSOCKET, R.I. MinuteClinic is offering free A1c tests, sponsored by Bayer Diabetes Care, through June 12 to help those patients with diabetes to monitor their blood sugar levels.
As part of the free A1c test, MinuteClinic practitioners will check a patient’s vital signs, review medical history and administer the blood test. Results are available within five minutes and are discussed with the patient. A visit summary that includes the A1c test results is made available to primary care providers with patient permission. Visit summaries are typically sent within 24 hours via electronic medical record, fax or mail.
“The hemoglobin A1c test is the best measure available to help the more than 24 million Americas with diabetes monitor their condition and prevent other health-related issues from arising,” stated Andrew Sussman, M.D., president of MinuteClinic and SVP/associate chief medical officer of CVS Caremark. “With hundreds of walk-in medical centers in stores located near where patients live and work, MinuteClinic is a tremendous resource for diabetes to receive lab testing and speak with a nurse practitioner about their health status.”
In addition to daily self-testing of glucose levels, diabetics should receive regular A1c tests that measure their average blood glucose levels over a two- or three-month period. The American Association advises that patients keep their A1c level below 7%. The A1c tests are not offered at MinuteClinic locations in Maryland, Massachusetts, Nevada and Pennsylvania.
Reports: Billionaire investor seeks to push out Genzyme CEO
NEW YORK Billionaire investor Carl Icahn is trying to kick Genzyme CEO Henri Termeer off the company’s board of directors, according to published reports.
The New York Times reported this week that Icahn had filed a proxy statement with the Securities and Exchange Commission saying he wanted to replace four of the company’s executives, calling the company “broken.” The biotech manufacturer has recently faced manufacturing problems leading to shortages of two of its drugs.
On Thursday, Genzyme announced that it would buy back $2 billion worth of stock and also seek to offload its genetic testing, diagnostic products and pharmaceutical intermediates businesses by spinning them off, divestiture or management buyouts.
“Genetics and diagnostics are strong businesses that are both leaders in their fields,” Termeer said. “However, as we evaluated our company to create a mix of businesses that will delivery sustainable growth and stronger returns on invested capital, it became clear that these businesses do not fit within this strategy.”
Whole Foods Market opens new flagship in Southern California
TARZANA, Calif. Whole Foods Market announced that it is opening its newest flagship store in Tarzana, Calif.
According to company, the 30,000-sq.-ft. sales floor will feature all the local, natural and organic products that Whole Foods Market customers expect plus a collection of specialties designed to bring the community’s favorite international flavors to Whole Foods Market’s newest location. The store will feature sit-down eateries, a wine bar and the largest olive bar in Los Angeles, according to Whole Foods.
“On behalf of the store’s 200 team members and our local businesses, farmers and vendor partners, I would like to thank the Tarzana community for the warm welcome,” said George Khoury, Whole Foods Market Tarzana store team leader. “We are proud to be a part of this exciting and unique neighborhood and look forward to building strong relationships with our neighboring businesses and families. We hope to be more than your local grocery store — we’d love to be your neighborhood gathering place.”